Pioneering Liquid Biopsies with MRD in Oncology for Accelerated Approval in Multiple Myeloma
Time: 11:30 am
day: Day One AM
Details:
- Understanding the significance of MRD as a key treatment response indicator in multiple myeloma
- Demonstrating the evidence of MRD negativity predicting long-term survival
- Pioneering novel approvals for MRD as clinical endpoints
